Australia markets closed

GlaxoSmithKline plc (GLAXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
19.46-0.53 (-2.65%)
At close: 11:39AM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 598.59B
Enterprise value 3128.82B
Trailing P/E 16.08
Forward P/E 112.22
PEG ratio (5-yr expected) 13.43
Price/sales (ttm)2.14
Price/book (mrq)4.56
Enterprise value/revenue 33.92
Enterprise value/EBITDA 712.13

Trading information

Stock price history

Beta (5Y monthly) 0.39
52-week change 316.18%
S&P500 52-week change 339.86%
52-week high 321.51
52-week low 316.50
50-day moving average 319.21
200-day moving average 319.42

Share statistics

Avg vol (3-month) 356.84k
Avg vol (10-day) 356.61k
Shares outstanding 55.03B
Implied shares outstanding 6N/A
Float 84.89B
% held by insiders 11.22%
% held by institutions 152.29%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.1
Forward annual dividend yield 45.48%
Trailing annual dividend rate 30.80
Trailing annual dividend yield 34.00%
5-year average dividend yield 45.31
Payout ratio 492.27%
Dividend date 313 Apr 2016
Ex-dividend date 418 Aug 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 June 2021


Profit margin 13.34%
Operating margin (ttm)24.85%

Management effectiveness

Return on assets (ttm)6.32%
Return on equity (ttm)24.29%

Income statement

Revenue (ttm)32.9B
Revenue per share (ttm)6.59
Quarterly revenue growth (yoy)6.10%
Gross profit (ttm)23.21B
Net income avi to common (ttm)4.39B
Diluted EPS (ttm)1.20
Quarterly earnings growth (yoy)-38.40%

Balance sheet

Total cash (mrq)3.56B
Total cash per share (mrq)0.71
Total debt (mrq)25.48B
Total debt/equity (mrq)118.10
Current ratio (mrq)0.82
Book value per share (mrq)3.07

Cash flow statement

Operating cash flow (ttm)6.34B
Levered free cash flow (ttm)6.95B